Gemeinschaftspraxis Melcherstätte - Dr. L. Pohlmeier, T. Drescher

At Gemeinschaftspraxis Melcherstätte - Dr. L. Pohlmeier, T. Drescher in Stuhr, much of the clinical research focuses on cardiovascular diseases, especially atherosclerotic cardiovascular disease, atrial fibrillation, heart failure, hypertension, and hyperlipidemia. The trials are mainly designed to test new treatments and compare them with existing care to help reduce major heart and blood vessel events.

• Studies in atherosclerotic cardiovascular disease and high-risk patients are evaluating ways to lower the chance of heart attack, stroke, and other major complications.
• Research in atrial fibrillation is focused on preventing cardioembolic events and improving protection against stroke.
• Trials in heart failure, including patients with preserved or mildly reduced ejection fraction, are exploring better symptom control and fewer hospital visits.

This therapeutic area reflects a strong emphasis on improving long-term outcomes for people with established cardiovascular disease and related risk factors such as type 2 diabetes, chronic kidney disease, and obesity.

The site also supports research in respiratory tract diseases, with trials centered on acute bronchitis and virus-related respiratory illness. These studies aim to assess whether new or alternative treatments can improve recovery and ease symptoms more effectively.

• Acute bronchitis studies are examining treatment effectiveness by comparing symptom improvement and overall tolerability.
• Respiratory infection research includes efforts to better prevent or manage illness caused by respiratory syncytial virus and human metapneumovirus.

This work highlights a practical focus on common respiratory conditions and on finding better ways to protect older adults and other vulnerable groups from serious infection.

Clinical trials in virus diseases at this research site include studies of influenza and respiratory viruses such as RSV and hMPV. The main purpose is to evaluate vaccines and preventive strategies that may reduce infection risk and disease burden.

• Influenza research is assessing vaccine safety, immune response, and protection against confirmed illness.
• Trials involving RSV and human metapneumovirus are testing whether vaccination can prevent lower respiratory tract disease in older adults.

These studies strengthen the site’s role in preventive research, with a clear focus on improving protection against seasonal and age-related viral infections.